Cytosorbents Crp Capital Reinvestment Ratio
Latest as of June 2020:
0.26x
Cytosorbents Crp capital reinvestment ratio. Cytosorbents Crp (CTSO) has a Capital Reinvestment Ratio of 0.26x as of June 2020, meaning it reinvests 0% of its operating cash flow ($1.94 Million) in capital expenditures ($497.36K). Check CTSO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
$1.94 Million
USD
Capital Expenditures
$497.36K
USD
Data as of
Jun 2020
Most recent filing
Cytosorbents Crp Capital Reinvestment Ratio by Year (None–None)
Cytosorbents Crp capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see CTSO cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow